Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 21,601 | 29,602 | 27,219 | 23,222 | 33,293 |
| Operating Income | -21,601 | -29,602 | -27,219 | -23,222 | -33,293 |
| Other Income | 1,506 | 1,316 | 1,040 | 502 | 435 |
| Pre-tax Income | -20,095 | -28,286 | -26,179 | -22,720 | -32,858 |
| Net Income Continuous | -20,095 | -28,286 | -26,179 | -22,720 | -32,858 |
| Net Income | $-20,095 | $-28,286 | $-26,179 | $-22,720 | $-32,858 |
| EPS Basic Total Ops | -0.49 | -0.70 | -0.65 | -0.57 | -0.82 |
| EPS Basic Continuous Ops | -0.49 | -0.70 | -0.65 | -0.57 | -0.82 |
| EPS Diluted Total Ops | -0.49 | -0.70 | -0.65 | -0.57 | -0.82 |
| EPS Diluted Continuous Ops | -0.49 | -0.70 | -0.65 | -0.57 | -0.82 |
| EBITDA(a) | $-21,502 | $-29,502 | $-27,122 | $-23,131 | $-33,214 |